430 related articles for article (PubMed ID: 29450766)
1. Septal myectomy for hypertrophic cardiomyopathy: important surgical knowledge and technical tips in the era of increasing alcohol septal ablation.
Chiang YP; Shimada YJ; Ginns J; Weiner SD; Takayama H
Gen Thorac Cardiovasc Surg; 2018 Apr; 66(4):192-200. PubMed ID: 29450766
[TBL] [Abstract][Full Text] [Related]
2. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
[TBL] [Abstract][Full Text] [Related]
3. Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Transcoronary and Endocardial Approach.
Aksu T; Guler T; Yalin K; Golcuk SE; Ozcan K
Am J Med Sci; 2016 Nov; 352(5):466-471. PubMed ID: 27865293
[TBL] [Abstract][Full Text] [Related]
4. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.
Veselka J
Med Sci Monit; 2007 Apr; 13(4):RA62-8. PubMed ID: 17392660
[TBL] [Abstract][Full Text] [Related]
5. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
6. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
Poon SS; Field M; Gupta D; Cameron D
Interact Cardiovasc Thorac Surg; 2017 Jun; 24(6):951-961. PubMed ID: 28329292
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter septal ablation in hypertrophic obstructive cardiomyopathy: a technical guide and review of published results.
Rigopoulos AG; Sakellaropoulos S; Ali M; Mavrogeni S; Manginas A; Pauschinger M; Noutsias M
Heart Fail Rev; 2018 Nov; 23(6):907-917. PubMed ID: 29736811
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy.
Liebregts M; Vriesendorp PA; Mahmoodi BK; Schinkel AF; Michels M; ten Berg JM
JACC Heart Fail; 2015 Nov; 3(11):896-905. PubMed ID: 26454847
[TBL] [Abstract][Full Text] [Related]
9. The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system.
Fitzgerald P; Kusumoto F
J Interv Card Electrophysiol; 2018 Aug; 52(3):403-408. PubMed ID: 30097789
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
Sedehi D; Finocchiaro G; Tibayan Y; Chi J; Pavlovic A; Kim YM; Tibayan FA; Reitz BA; Robbins RC; Woo J; Ha R; Lee DP; Ashley EA
J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885
[TBL] [Abstract][Full Text] [Related]
11. Alcohol septal ablation: A useful tool in our arsenal against hypertrophic obstructive cardiomyopathy.
Savarimuthu S; Harky A
J Card Surg; 2020 Aug; 35(8):2017-2024. PubMed ID: 32652778
[TBL] [Abstract][Full Text] [Related]
12. Alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in patients with prior coronary revascularization.
Khouzam RN; Naidu SS
J Invasive Cardiol; 2010 Dec; 22(12):E220-4. PubMed ID: 21127375
[TBL] [Abstract][Full Text] [Related]
13. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort.
Nguyen A; Schaff HV; Hang D; Nishimura RA; Geske JB; Dearani JA; Lahr BD; Ommen SR
J Thorac Cardiovasc Surg; 2019 Jan; 157(1):306-315.e3. PubMed ID: 30279000
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of obstructive hypertrophic cardiomyopathy: the gold standard.
Brown ML; Schaff HV
Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):715-22. PubMed ID: 18510487
[TBL] [Abstract][Full Text] [Related]
15. Endocardial septal ablation for hypertrophic obstructive cardiomyopathy.
Aksu T; Güler TE; Yalın K; Gölcük ŞE; Özcan KS
Turk Kardiyol Dern Ars; 2017 Jan; 45(1):67-72. PubMed ID: 28106021
[TBL] [Abstract][Full Text] [Related]
16. Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients.
Maron BJ; Yacoub M; Dearani JA
Eur Heart J; 2011 May; 32(9):1055-8. PubMed ID: 21324934
[TBL] [Abstract][Full Text] [Related]
17. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes.
Firoozi S; Elliott PM; Sharma S; Murday A; Brecker SJ; Hamid MS; Sachdev B; Thaman R; McKenna WJ
Eur Heart J; 2002 Oct; 23(20):1617-24. PubMed ID: 12323162
[TBL] [Abstract][Full Text] [Related]
18. Predictors of long-term outcome after septal myectomy in symptomatic hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation and residual obstruction.
Zhu C; Tang B; Cui H; Wang S; Xiao M; Chen Z; Meng Y; Zhao S; Song Y; Yu Q; Wang S
J Card Surg; 2019 Jul; 34(7):533-540. PubMed ID: 31111576
[TBL] [Abstract][Full Text] [Related]
19. Selection of hypertrophic cardiomyopathy patients for myectomy or alcohol septal ablation.
Lever HM
Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():27-30. PubMed ID: 17162266
[TBL] [Abstract][Full Text] [Related]
20. Myectomy versus alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Afanasyev AV; Bogachev-Prokophiev AV; Kashtanov MG; Astapov DA; Zalesov AS; Budagaev SA; Sharifulin RM; Idov EM; Zheleznev SI
Interact Cardiovasc Thorac Surg; 2020 Aug; 31(2):158-165. PubMed ID: 32386304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
